Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement inhibitor to anti-C5 therapy: A lesson not to be forgotten.

Autor: Risitano AM; AORN Moscati, Hematology, Avellino, Italy.; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy., Frieri C; AORN Moscati, Hematology, Avellino, Italy., Marano L; AORN Moscati, Hematology, Avellino, Italy., Urciuoli E; AORN Moscati, Hematology, Avellino, Italy., Sanseverino A; AORN Moscati, Hematology, Avellino, Italy., Nannelli C; Laboratory of Cancer Genetics and Gene Transfer, Core Research Laboratory-Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Notaro R; Laboratory of Cancer Genetics and Gene Transfer, Core Research Laboratory-Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.; Hematology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2024 Oct 12. Date of Electronic Publication: 2024 Oct 12.
DOI: 10.1002/ajh.27502
Databáze: MEDLINE
Externí odkaz: